Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1998 1
2006 2
2007 2
2008 1
2009 2
2010 1
2011 3
2012 5
2013 5
2014 3
2015 1
2016 2
2017 3
2019 5
2020 5
2021 5
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Structure of Dark Triad Dirty Dozen Across Eight World Regions.
Rogoza R, Żemojtel-Piotrowska M, Jonason PK, Piotrowski J, Campbell KW, Gebauer JE, Maltby J, Sedikides C, Adamovic M, Adams BG, Ang RP, Ardi R, Atitsogbe KA, Baltatescu S, Bilić S, Bodroža B, Gruneau Brulin J, Bundhoo Poonoosamy HY, Chaleeraktrakoon T, Del Carmen Dominguez A, Dragova-Koleva S, El-Astal S, Eldesoki WLM, Gouveia VV, Gundolf K, Ilisko D, Jukić T, Kamble SV, Khachatryan N, Klicperova-Baker M, Kovacs M, Kozytska I, Larzabal Fernandez A, Lehmann K, Lei X, Liik K, McCain J, Milfont TL, Nehrlich A, Osin E, Özsoy E, Park J, Ramos-Diaz J, Riđić O, Qadir A, Samekin A, Tiliouine H, Tomsik R, Umeh CS, van den Bos K, Van Hiel A, Vauclair CM, Włodarczyk A. Rogoza R, et al. Among authors: bilic s. Assessment. 2021 Jun;28(4):1125-1135. doi: 10.1177/1073191120922611. Epub 2020 Jun 2. Assessment. 2021. PMID: 32484407
Country-level correlates of the Dark Triad traits in 49 countries.
Jonason PK, Żemojtel-Piotrowska M, Piotrowski J, Sedikides C, Campbell WK, Gebauer JE, Maltby J, Adamovic M, Adams BG, Kadiyono AL, Atitsogbe KA, Bundhoo HY, Bălțătescu S, Bilić S, Brulin JG, Chobthamkit P, Del Carmen Dominguez A, Dragova-Koleva S, El-Astal S, Esteves CS, Labib M Eldesoki W, Gouveia VV, Gundolf K, Ilisko D, Jauk E, Kamble SV, Khachatryan N, Klicperova-Baker M, Knezovic E, Kovacs M, Lei X, Liik K, Mamuti A, Moreta-Herrera CR, Milfont TL, Wei Ong C, Osin E, Park J, Petrovic B, Ramos-Diaz J, Ridic G, Qadir A, Samekin A, Sawicki A, Tiliouine H, Tomsik R, Umeh CS, van den Bos K, Van Hiel A, Uslu O, Wlodarczyk A, Yahiiaev I. Jonason PK, et al. Among authors: bilic s. J Pers. 2020 Dec;88(6):1252-1267. doi: 10.1111/jopy.12569. Epub 2020 Jul 1. J Pers. 2020. PMID: 32557617
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy.
Barrett D, Bilic S, Chyung Y, Cote SM, Iarrobino R, Kacena K, Kalra A, Long K, Nomikos G, Place A, Still JG, Vrishabhendra L. Barrett D, et al. Among authors: bilic s. Adv Ther. 2021 Jun;38(6):3203-3222. doi: 10.1007/s12325-021-01757-z. Epub 2021 May 8. Adv Ther. 2021. PMID: 33963971 Free PMC article. Clinical Trial.
43 results